showed that mice treated with GVAX experienced the highest survival rates when treated with anti-PD-1 and anti-CSF1R inhibition, which modified the myeloid compartment of tumours inside a model of murine pancreatic cancer [104]

showed that mice treated with GVAX experienced the highest survival rates when treated with anti-PD-1 and anti-CSF1R inhibition, which modified the myeloid compartment of tumours…